West Pharmaceutical Services, Inc.

BMV:WST * Rapporto sulle azioni

Cap. di mercato: Mex$464.8b

West Pharmaceutical Services Performance dei guadagni passati

Il passato criteri di controllo 2/6

West Pharmaceutical Services has been growing earnings at an average annual rate of 13.8%, while the Life Sciences industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 9.8% per year. West Pharmaceutical Services's return on equity is 18.2%, and it has net margins of 17.4%.

Informazioni chiave

13.8%

Tasso di crescita degli utili

13.8%

Tasso di crescita dell'EPS

Life Sciences Crescita del settore12.9%
Tasso di crescita dei ricavi9.8%
Rendimento del capitale proprio18.2%
Margine netto17.4%
Ultimo aggiornamento sui guadagni30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Ripartizione dei ricavi e delle spese

Come West Pharmaceutical Services guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

BMV:WST * Ricavi, spese e utili (USD Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Sep 242,87650034269
30 Jun 242,87752534970
31 Mar 242,92956935569
31 Dec 232,95059335468
30 Sep 232,92755929966
30 Jun 232,86651932663
31 Mar 232,88455231961
31 Dec 222,88758631659
30 Sep 222,90963137756
30 Jun 222,92968635256
31 Mar 222,88168436255
31 Dec 212,83266235653
30 Sep 212,68161334052
30 Jun 212,52351931051
31 Mar 212,32642330848
31 Dec 202,14734630147
30 Sep 202,03731229144
30 Jun 201,94528629741
31 Mar 201,88826127740
31 Dec 191,84024227339
30 Sep 191,79223026239
30 Jun 191,76722925939
31 Mar 191,74521925841
31 Dec 181,71720725640
30 Sep 181,71115525740
30 Jun 181,67715125639
31 Mar 181,62713324838
31 Dec 171,59915124339
30 Sep 171,56619024539
30 Jun 171,54417624239
31 Mar 171,53518224338
31 Dec 161,50914423837
30 Sep 161,48713824137
30 Jun 161,45410223837
31 Mar 161,4268524636
31 Dec 151,4009624334
30 Sep 151,3909424032
30 Jun 151,40112324133
31 Mar 151,41113322835
31 Dec 141,42112722937
30 Sep 141,41411923039
30 Jun 141,40011523039
31 Mar 141,37610823239
31 Dec 131,36811223538

Guadagni di qualità: WST * has high quality earnings.

Margine di profitto in crescita: WST *'s current net profit margins (17.4%) are lower than last year (19.1%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: WST *'s earnings have grown by 13.8% per year over the past 5 years.

Accelerare la crescita: WST *'s has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Guadagni vs Settore: WST * had negative earnings growth (-10.7%) over the past year, making it difficult to compare to the Life Sciences industry average (-5.7%).

Rendimento del capitale proprio

ROE elevato: WST *'s Return on Equity (18.2%) is considered low.

Rendimento delle attività

Rendimento del capitale investito

Scoprire le aziende con forti performance passate

7D

1Y

7D

1Y

7D

1Y